First Time Loading...

Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 106.81 USD 1.46%
Updated: Apr 19, 2024
ABT
/
Income Statement
/
Revenue

Abbott Laboratories
Revenue

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

Abbott Laboratories
Revenue Peer Comparison

Comparables:
BDX
BSX
EW
SYK
ISRG

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Abbott Laboratories
NYSE:ABT
Revenue
$40.1B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
7%
Becton Dickinson and Co
NYSE:BDX
Revenue
$19.5B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$14.2B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
7%
Edwards Lifesciences Corp
NYSE:EW
Revenue
$6B
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Revenue
$20.5B
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
9%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.1B
CAGR 3-Years
18%
CAGR 5-Years
14%
CAGR 10-Years
12%

Abbott Laboratories
Revenue Breakdown

Breakdown by Geography
Abbott Laboratories

Total Revenue: 40.1B USD
100%
International: 24.7B USD
61.5%
United States: 15.5B USD
38.5%
All Other Countries: 14.1B USD
35.1%
Germany: 2.3B USD
5.8%
China: 2.3B USD
5.6%
India: 1.8B USD
4.4%
Switzerland: 1.6B USD
4.1%
Japan: 1.5B USD
3.8%
Netherlands: 1.1B USD
2.7%
Show More
Show Less

Breakdown by Segments
Abbott Laboratories

Total Revenue: 40.1B USD
100%
Medical Devices: 16.9B USD
42.1%
Diagnostic Products: 10B USD
24.9%
Nutritional Products: 8.2B USD
20.3%
Established Pharmaceutical Products: 5.1B USD
12.6%
Show More
Show Less

See Also

What is Abbott Laboratories's Revenue?
Revenue
40.1B USD

Based on the financial report for Dec 31, 2023, Abbott Laboratories's Revenue amounts to 40.1B USD.

What is Abbott Laboratories's Revenue growth rate?
Revenue CAGR 10Y
7%

Over the last year, the Revenue growth was -8%. The average annual Revenue growth rates for Abbott Laboratories have been 5% over the past three years , 6% over the past five years , and 7% over the past ten years .

ALPHA SPREAD
Join more than 129,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.